FAB — Fusion Antibodies Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual balance sheet for Fusion Antibodies, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	2.69	2.05	0.195	1.2	0.359
Net Total Accounts Receivable
Net Total Receivables	0.781	1.02	0.695	0.491	0.401
Total Inventory
Prepaid Expenses
Total Current Assets	4.71	4.28	1.69	2.26	1.26
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.12	0.633	0.375	0.158	0.063
Net Intangible Assets
Other Long Term Assets
Total Assets	5.83	4.92	2.06	2.42	1.32
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.996	1.21	0.879	0.584	0.623
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1.08	1.23	0.939	0.627	0.654
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	4.75	3.68	1.12	1.79	0.669
Total Liabilities & Shareholders' Equity	5.83	4.92	2.06	2.42	1.32
Total Common Shares Outstanding